The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation. “States have enacted COPAs with the assumption that regulatory oversight can mitigate the effects of lost competition and may allow hospitals to achieve certain efficiencies,” FTC said. “The Commission is interested in empirical research on the actual benefits and harms associated with COPAs, and on qualitative analyses of stakeholders’ experience with COPAs. Such studies and analyses, as well as the information presented at this workshop, may help advance the agency’s policy and enforcement strategies.” The workshop is part of FTC’s COPA Assessment Project

Perspective
Public
Every day, hospitals and health systems are finding new and better ways to care for the people and communities they serve.You can see it in predictive…
Headline
The AHA Rural Hospital Excellence in Innovation Award, sponsored by Microsoft, recognizes and shares the accomplishments of rural hospitals that …
Headline
The Food and Drug Administration April 28 announced its plan to advance the implementation of real-time clinical trials, which invite participants to supply…
Blog
Public
The American Hospital Association Leadership Summit will take place July 12-14 at the Colorado Convention Center in Denver. Renowned speakers from across…
Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Headline
The AHA today announced that it will present Harsh K. Trivedi, M.D., president and CEO of Sheppard Pratt health system in Baltimore, with the 2026…